Nycomed, Orion sales and marketing update

The companies partnered to co-market Easyhaler combination products being developed by Orion for the treatment of asthma and chronic obstructive pulmonary disease (COPD) in European countries, including Austria, the Benelux countries, France, Germany, Greece, Italy, Poland, Portugal, Spain and Switzerland. Orion will retain marketing rights in the Nordic countries, U.K. and Eastern Europe and will exclusively manufacture all products under the deal. Nycomed also received an exclusive license to market Easyhaler products in the Middle East and North African region. Details were not disclosed. ...